School of Medicine
Showing 1-10 of 44 Results
Associate Professor of Medicine (General Medical Disciplines) and, by courtesy, of Health Research and Policy (Epidemiology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
Manjula Kurella Tamura
Professor of Medicine (Nephrology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly Interests I am a clinical and health services investigator whose primary interest is in improving the quality of end-stage renal disease (ESRD) care among older adults. My previous and current work aims to describe outcomes (especially geriatric outcomes) in older patients and to compare the effectiveness of different ESRD management strategies on these outcomes.
Jane C. Tan
Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research relates to issues pertaining to clinical kidney transplantation. We have ongoing studies on the following topics.
1. Renal senescence and kidney transplant, and chronic allograft nephropathy.
2. Living donor safety and response to uninephrectomy.
3. Biomarkers for post-transplant monitoring.
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Current Research and Scholarly Interests Type 2 diabetes, obesity, insulin resistance
Melinda L. Telli, M.D.
Associate Professor of Medicine (Oncology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research focuses on the development of novel therapies for the treatment of triple-negative and hereditary cancer. Other areas of interest include prevention of cardiac damage associated with breast cancer treatment and cardiotoxicity of anti-cancer agents.